Can age at sexual maturity act as a predictive biomarker for prodromal negative symptoms?

Schizophr Res. 2015 May;164(1-3):35-9. doi: 10.1016/j.schres.2015.02.019. Epub 2015 Mar 14.

Abstract

Background: Puberty and reproductive hormones have been identified as having a potential role in schizophrenia. Earlier reports have suggested associations between later age at puberty and schizophrenia in males. Similarly, associations have been reported between testosterone levels and psychotic symptoms. In this report, we examined the association between age at puberty and prodromal symptoms of psychosis.

Methods: 58 child or adolescent family members of individuals with schizophrenia were interviewed using the Scale of Prodromal Symptoms and the Tanner Maturational Scale. Age at Tanner pubertal stage was determined and regression analyses were used to explore associations between prodromal symptoms and age at puberty.

Results: Among males, delayed age at puberty was associated with greater severity of prodromal symptoms; the association between negative prodromal symptoms and delayed age was significant (p=0.001). In females, the association was not statistically significant.

Conclusions: Our results suggest that delayed age at puberty may be associated with negative prodromal symptoms of schizophrenia in males. Our findings suggest that delayed age at puberty could potentially be a predictive biomarker for psychopathology in males at risk for schizophrenia.

Keywords: Biomarker; Negative symptoms; Psychosis; Puberty; Tanner stage.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Aging*
  • Biomarkers / metabolism*
  • Child
  • Female
  • Humans
  • Male
  • Prodromal Symptoms*
  • Psychiatric Status Rating Scales
  • Regression Analysis
  • Risk Factors
  • Schizophrenia / diagnosis*
  • Schizophrenia / metabolism*

Substances

  • Biomarkers